4D Molecular Therapeutics CLO Scott Bizily disposes of common shares worth $39,567.5

4D Molecular Therapeutics Chief Legal Officer Scott Bizily exercised stock options on August 13 and 17 at $4.14 per share. He subsequently sold 3,270 common shares at prices of $12 and $12.20 on those respective dates, totaling approximately $39,567.50 in sales. Following these transactions, Bizily directly holds 8,617 common shares.

4D Molecular Therapeutics Chief Legal Officer Scott Bizily exercised stock options on Aug. 13 and Aug. 17 at $4.14. * Sold 3,270 common shares at $12 and $12.2 on the same dates. * Directly held 8,617 common shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-354313), on August 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here